Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-04

Clinical Trial Update: Phase III Clinical Trial of "Botulax®" to Treat Children With Cerebral Palsy [Phase 3]

View source ↗

Summary

A Phase 3 trial of Botulax for treating cerebral palsy in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulax (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Other Infantile Cerebral Palsy | Phase 3 | Status: COMPLETED